Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
P&G: Worrying signs - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Apr 25, 2002

    P&G: Worrying signs

    P&G Hygiene & Healthcare Limited's (P&G) third quarter performance reflects the difficult market conditions the FMCG sector has been facing. The company declared a 9% topline growth in the December quarter, but finished the March quarter with a significant 11% decline in topline growth.

    (Rs m) 3QFY01 3QFY02 Change 9m FY01 9m FY02 Change
    Net Sales 908 805 -11.3% 3,240 3,205 -1.1%
    Other Income 39 19 -50.9% 64 73 14.2%
    Expenditure 612 626 2.4% 2,284 2,361 3.4%
    Operating Profit (EBDIT) 296 179 -39.7% 956 843 -11.8%
    Operating Profit Margin (%) 32.6% 22.2%   29.5% 26.3%  
    Interest 0 0   1 0  
    Depreciation 70 37 -47.2% 213 158 -25.6%
    Profit before Tax 266 161 -39.4% 806 758 -6.0%
    Extraordinary items 0 0   0 73  
    Tax 57 40 -29.8% 91 168 83.7%
    Profit after Tax/(Loss) 208 121 -42.0% 715 663 -7.3%
    Net profit margin (%) 22.9% 15.0%   22.1% 20.7%  
    No. of Shares (eoy) (m) 21.6 21.6   21.6 21.6  
    Earnings per share* 38.5 22.3   44.1 40.9  
    Current P/e ratio   20.8     11.4  

    The company finished the quarter with a 42% decline in profits to Rs 121 m. However, the company's release says that P&G had earned an extraordinary income of Rs 100.5 m in March quarter last year, and therefore, has actually registered a 12% growth in net profit YoY. This extraordinary income must have arisen due to sales adjustments in the March quarter last year.

    However, in March quarter last year the company did not elaborate on how these extraordinary gains came about. The management of P&G seems to be giving this aspect prominence now. How this extraordinary item affected the March quarter numbers in the previous year is therefore not clear to us, so we are keeping our last year's March quarter figures intact.

    Cost break-up
    (Rs m) 3QFY01 3QFY02 Change 9m FY01 9m FY02 Change
    Raw material cost 403 323 -19.9% 1,312 1,288 -1.9%
    Staff cost 105 70 -33.4% 274 237 -13.4%
    Sales tax/excise 103 104 0.7% 332 337 1.7%
    Other expenses 103 234 126.0% 698 837 19.9%
    Total expenditure 715 730 2.2% 2,615 2,698 3.2%

    Apart from the decline in topline, another worrying aspect is a huge 10% drop in operating margins to 22%. This is another sign of the difficult market conditions P&G is facing. On a nine month basis, the performance is somewhat better. The company has logged in a marginal 1% decline in sales and a 7% drop in net profits. If we take out the extraordinary income P&G earned in FY02 (till date) then the company actually saw profits decline by 17% during the nine month period. In 9mFY02 too, the pressure on margins is evident.

    Commenting on the performance Mr. Bharat Patel, Chairman, P&G said "Our third quarter sales are down because of continuing slowdown in economy resulting in decline in most established packaged consumer goods category. We have strong plans for the remaining part of the fiscal and next year so that sales decline turns into significant sales increase"

    At the current price of Rs 465 the stock trades at a P/E of 11x 9mFY02 annualised earnings. Given the company's focus on operational efficiencies, the valuation is on the lower side. This is probably because of the company's two product dependence as well as concerns regarding the parent's 100% subsidiaries. Also, the company's 3QFY02 performance is sending warning signals about the pressure on the company's core business.



    Equitymaster requests your view! Post a comment on "P&G: Worrying signs". Click here!


    More Views on News

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    P&G: Strong Core Performance (Quarterly Results Update - Detailed)

    Oct 5, 2016

    Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: A Stable Quarter (Quarterly Results Update - Detailed)

    May 6, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 12% YoY during the quarter.

    P&G: Margins Go Through the Roof (Quarterly Results Update - Detailed)

    Feb 9, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 62% YoY during the quarter.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 18, 2017 (Close)


    • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks


    Compare Company With Charts